These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31959019)

  • 1. Long-term safety and efficacy studies of epinephrine HFA metered-dose inhaler (Primatene
    Kerwin EM; Tashkin DP; Korenblat PE; Greos LS; Pearlman DS; Bensch GW; Miller SD; Marrs T; Luo MZ; Zhang JY
    J Asthma; 2021 May; 58(5):633-644. PubMed ID: 31959019
    [No Abstract]   [Full Text] [Related]  

  • 2. A Dose-Ranging Study of Epinephrine Hydrofluroalkane Metered-Dose Inhaler (Primatene
    Kerwin EM; Tashkin DP; Murphy TR; Bensch GW; Marrs T; Luo MZ; Zhang JY
    J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):186-193. PubMed ID: 32150492
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic Study of Epinephrine Hydrofluoroalkane (Primatene MIST) Metered-Dose Inhaler.
    Kerwin EM; Marrs T; Luo MZ; Zhang JY
    J Aerosol Med Pulm Drug Deliv; 2020 Oct; 33(5):282-287. PubMed ID: 32423275
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.
    Goldberg J; Böhning W; Schmidt P; Freund E
    Respir Med; 2000 Oct; 94(10):948-53. PubMed ID: 11059947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
    Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
    Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
    Huchon G; Hofbauer P; Cannizzaro G; Iacono P; Wald F
    Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
    Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial.
    Escribano A; Tutuncu A; Löhr I; Carlholm M; Polanowski T
    Curr Med Res Opin; 2006 Jun; 22(6):1085-92. PubMed ID: 16846541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of long-term treatment with HFA albuterol.
    Ramsdell JW; Klinger NM; Ekholm BP; Colice GL
    Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
    Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
    Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
    Lumry W; Noveck R; Weinstein S; Barnhart F; Vandermeer A; Murray A; Reisner C
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence.
    Singh D; Tutuncu A; Lohr I; Carlholm M; Polanowski T
    Int J Clin Pharmacol Ther; 2007 Sep; 45(9):485-95. PubMed ID: 17907591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
    Kerwin EM; Taveras H; Iverson H; Wayne D; Shah T; Lepore MS; Miller DS
    Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG; Millar AB; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E; Ekholm BP; Klinger NM; Colice GL
    J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.